Ilya Kazantsev
0000-0002-3818-6213
12 papers found
Refreshing results…
Post‐transplant сyclophosphamide after matched donor hematopoietic stem cell transplantation in children with acute leukemia
Mechanisms of central nervous system damage in COVID-19
The treatment of relapsed/refractory anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase: a single-center experience
Autologous hematopoietic stem cell transplantation in children with relapsed or refractory Hodgkin lymphoma
Tandem autologous hematopoietic stem cell transplantation for embryonal brain tumors in infants and very young children
Immunotherapy by anti-GD2 antibodies in patients with primary high-risk neuroblastoma, primary resistant and relapsed disease: Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of St. Petersburg experience
Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
High-dose polychemotherapy with autologous hematopoietic stem cell transplantation in children with non-Hodgkin lymphomas
Allogeneic hematopoietic stem cell transplantation in children with lymphoblastic lymphoma
No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
The complex intensive therapy regimen as curative therapy in patients with primary-resistant and relapsed neuroblastoma: R.M. Gorbacheva Memorial Institute for Children Oncology, Hematology and Transplantation experience
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in high-risk neuroblastoma patients: Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of St. Petersburg experience
Missing publications? Search for publications with a matching author name.